La prevalencia del síndrome metabólico en mujeres postmenopáusicas
| dc.contributor.author | Urina-Jassir, Daniela | |
| dc.contributor.author | Urina-Jassir, Manuel | |
| dc.contributor.author | Urina-Triana, Miguel | |
| dc.contributor.author | Mantilla-Morrón, Mirary | |
| dc.contributor.author | Urina-Triana, Manuel | |
| dc.contributor.author | Galeano-Muñoz, Luisa | |
| dc.date.accessioned | 2019-01-16T14:28:16Z | |
| dc.date.available | 2019-01-16T14:28:16Z | |
| dc.date.issued | 2018 | |
| dc.description.abstract | Introducción y Objetivos: El desarrollo del aumento de la grasa central abdominal, de la alteración del perfil lipídico y de la resistencia a la insulina encontrado en el síndrome metabólico están mayormente presentes en la menopausia. Conocer la prevalencia del SM en mujeres postmenopáusicas en Barranquilla, permitirá desarrollar estrategias futuras para disminuir su presencia y la de las enfermedades cardiovasculares. Material y Métodos: Estudio transversal, realizado en Barranquilla, Colombia entre octubre a noviembre 2016, en mujeres con edad laboral. El diagnóstico del SM se hizo con al menos tres de los cinco criterios propuestos por el consenso de la Federación Internacional de Diabetes, del Instituto Nacional del Corazón, Pulmón y Sangre, de la Asociación Americana del Corazón, de la Federación Mundial del Corazón, de la Sociedad Internacional de Aterosclerosis y de la Asociación Internacional para el Estudio de la Obesidad. Resultados: Se incluyeron 773 mujeres, 78,65% premenopaúsicas (n=608) y 21,35% post- menopáusicas (n=165). El 27,8% (n=46) de mujeres post-menopáusicas tenían SM vs. 14,6% (n=89) de las pre-menopaúsicas, con una diferencia estadísticamente significativa de p<0,0001 (Chi-cuadrado 15.7845). Conclusiones: En las mujeres post-menopáusicas se manifestó una mayor incidencia de SM cuando se compara con las pre-menopaúsicas, por lo que se incrementa el riesgo cardiovascular. Se sugiere que deberían ser tratadas en forma temprana con el fin de reducir su mortalidad. | spa |
| dc.description.abstract | Introduction and Objectives: Menopause represents a transition in female reproductive life, which has been associated with the development of typical characteristics of metabolic syndrome (MetS). These include increased abdominal central fat, impaired lipid profile and insulin resistance. Awareness MetS and its prevalence in pre and post-menopausal women, will be useful in developing future strategies to reduce its presence and with-it cardiovascular disease. Material and methods: This was a cross-sectional study, conducted in Barranquilla, Colombia between October and November 2016, in women of working age. The diagnosis of MetS was made with at least three of the five criteria proposed by the consensus of the International Diabetes Federation, the National Heart, Lung and Blood Institute, the American Heart Association, the World Heart Federation, the International Society of Atherosclerosis and the International Association for the Study of Obesity. Results: A total of 773 women were enrolled in our study, from which 78.65% were pre-menopausal (n=608) and 21.35% post-menopausal (n=165). The presence of MetS was seen in 27.8% (n=46) of post-menopausal in comparison to 14.6 % (n=89) of the pre-menopausal women, representing a statistically significant difference (Chisquare 15.7845 p <0.0001). Conclusions: MetS has a higher prevalence in postmenopausal women when compared to pre-menopausal women. As MetS is present, cardiovascular risk increases. This population should be identified early in time in order to screen, prevent and reduce their mortality. | eng |
| dc.identifier.issn | 18564550 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12442/2446 | |
| dc.language.iso | spa | spa |
| dc.publisher | Cooperativa servicios y suministros 212518 RS | spa |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess | |
| dc.rights.license | Licencia de Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional | spa |
| dc.source | Revista Latinoamericana de Hipertensión | spa |
| dc.source | Vol. 13, No. 4 (2018) | spa |
| dc.source.uri | http://www.revhipertension.com/rlh_4_2018/15_prevalencia_sindrome_metabolico.pdf | spa |
| dc.subject | Síndrome metabólico | spa |
| dc.subject | Post-menopausia | spa |
| dc.subject | Edad laboral | spa |
| dc.subject | Metabolic syndrome | eng |
| dc.subject | Post-menopausal | eng |
| dc.subject | Working age | eng |
| dc.title | La prevalencia del síndrome metabólico en mujeres postmenopáusicas | spa |
| dc.title.alternative | Prevalence of the metabolic syndrome in post-menopausal women | eng |
| dc.type | article | spa |
| dcterms.references | Reaven G, Hoffman B. A role for insulin in the etiology and course of hypertension? Lancet. 1987; 2:435-7. | eng |
| dcterms.references | Grant R, Meigs J. Should the insulin resistance syndrome be treated in the elderly? Drugs Aging. 2004; 21:141-51. | eng |
| dcterms.references | Lorenzo C, Williams K, Hunt K, Haffner S. The National Cholesterol Education Program- Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care. 2007; 30: 8-13. | eng |
| dcterms.references | Cubillos-Garzón LA, Casas JP, Morillo CA, Bautista L. Congestive heart failure in Latin America the next epidemic. Am Heart J. 2004;47(3):412-7. | eng |
| dcterms.references | Royer M, Castelo-Branco C, Blumel JE, Chedraui PA, Danckers L, Bencosme A, et al. The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III): prevalence of the metabolic syndrome in postmenopausal Latin American women. Climacteric. 2007;10(2):164-70. | eng |
| dcterms.references | Bustos P, da Silva AA, Amigo H, Bettiol H, Barbieri MA. Metabolic syndrome in young adults from two socioeconomic Latin American settings. Nutr Metab Cardiovasc Dis. 2007;17(8):581-9. | eng |
| dcterms.references | James WP. The epidemiology of obesity: the size of the problem. J Intern Med. 2008;263(4):336-52. | eng |
| dcterms.references | Rojas S, Lopera J, Cardona J, Vargas N, Hormaza M. Síndrome metabólico en la menopausia, conceptos clave. Rev. Chil Obstet Ginecol. 2014;79(2):121-128 | spa |
| dcterms.references | Ross LA, Polotsky AJ. Metabolic correlates of menopause: an update. Curr Opin Obstet Gynecol. 2012; 24(6):402-7. | eng |
| dcterms.references | van der Leeuw J, Wassink AM, van der Graaf Y, Westerveld HE, Visseren FL. On behalf of the Second Manifestations of ARTerial Disease (SMART) Study Group. Age-related differences in abdominal fat distribution in premenopausal and postmenopausal women with cardiovascular disease. Menopause. 2013;20(4):409-17. | eng |
| dcterms.references | Ebrahimpour P, Fakhrzadeh H, Heshmat R, Ghodsi M, Bandarian F, Larijani B. Metabolic syndrome and menopause: A population-based study. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2010; 4:5-9. | eng |
| dcterms.references | Lobo RA. Metabolic syndrome after menopause and the role of hormones. Maturitas. 2008;60(1):10-8. | eng |
| dcterms.references | Yoldemir T, Erenus M. The prevalence of metabolic syndrome in preand post-menopausal women attending a tertiary clinic in Turkey. Eur J Obstet Gynecol Reprod Biol. 2012; 164(2):172-5. | eng |
| dcterms.references | Ainy E, Mirmiran P, ZahediAsl S, Azizi F. Prevalence of metabolic syndrome during menopausal transition Tehranian women: Tehran Lipid and Glucose Study (TLGS). Maturitas. 2007;58(2):150-5. | eng |
| dcterms.references | American heart association. Heart Disease and Stroke Statistics – 2008 Update. Dallas, Tex: American Heart Association; 2008. | eng |
| dcterms.references | Melgarejo E, Urdinola J. Riesgo cardiovascular de la mujer menopáusica. Ed. Sociedad Colombiana de Cardiología, FECOLSOG 2011. Ed Panamericana 2012. | spa |
| dcterms.references | 2018-DANE Colombia Estadisticas vitales. http://www.dane.gov.co/ index.php/poblacion-y-demografia/nacimientos-y-defunciones/118- demograficas/estadisticas-vitales/2877 defunciones-no-fetales | spa |
| dcterms.references | Molina D, Muñoz D. Síndrome metabólico en la mujer. Rev Colomb de Cardiol. 2018;25(S1):21-29 | spa |
| dcterms.references | Sánchez F, Jaramillo N, Vanegas A, Echeverri J, León C, Echavarría E et al. Prevalencia y comportamiento de los factores de riesgo del síndrome metabólico según los diferentes intervalos de edad, en una población femenina del área de influencia de la Clínica Las Américas, en Medellín - Colombia. Rev. Col. Cardiol. 2008; 15(3): 102-110. | spa |
| dcterms.references | Aschner P, Chávez M, Izquierdo J, Sole J, Tarazona A, Pinzón JB, et al. Prevalence of the metabolic syndrome in a rural and urban population in Colombia. Diab Res Clin Prac 2002; 57 (Suppl 1): 532. | eng |
| dcterms.references | Villegas A, Botero J, Arango I, Arias S, Toro M. Prevalencia de síndrome metabólico en El Retiro, Colombia. IATREIA 2003; 16: 291-297 | spa |
| dcterms.references | Manzur F, De la Ossa M, Trespalacios E, Abuabara Y, Lujan M. Prevalencia del síndrome metabólico en el municipio de Arjona, Colombia. Rev Colomb Cardiol. 2008;15:215-222 | spa |
| dcterms.references | Urina-Jassir D, Urina-Triana M, Balaguera-Mendoza J, Montenegrorolong L, Urina Jassir M, Urina-Triana ME. Prevalencia del síndrome metabólico en hipertenso estadio I. Rev Colomb Cardiol. 2016; 23(5):365-374. | eng |
| dcterms.references | Alberti K, Eckel R, Grundy S, Zimmet P, Cleeman J, Donato K, et al. Harmonizing the metabolic syndrome. A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity Circulation. 2009; 120:1640-1645. | eng |
| dcterms.references | Aschner P, Buendía R, Brajkovich I, González A, Figueredo R, Juárez X, et al. Determination of the cut-off point for waist circumference that establishes the presence of abdominal obesity in Latin American men and women Diabetes Res Clin Pract. 2011; 93:243-247. | eng |
| dcterms.references | Tabares MK, Aguilera JR, Velázquez B, Garza P, Angulo LC, García R. Síndrome metabólico en menopausia: implicaciones de la terapia hormonal. Perinatol Reprod Hum. 2012;26(1):25-9. | spa |
| dcterms.references | Schmitt AC, Cardoso MR, Lopes H, Pereira WM, Pereira EC, de Rezende DA, et al. Prevalence of metabolic syndrome and associated factors in women aged 35 to 65 years who were enrolled in a family health program in Brazil. Menopause. 2013; 20(4):470-6. | eng |
| dcterms.references | Figueiredo Neto JA, Figuerêdo ED, Barbosa JB, Barbosa FF, Costa GRC, Nina VJS. et al. Metabolic syndrome and menopause: Cross-sectional study in gynecology clinic. Arq Bras Cardiol. 2010;95(3):339–45. doi: 10.1590/S0066-782X2010005000094. | eng |
| dcterms.references | Chedraui P, San Miguel G, Villacreses D, Dominguez A, Jaramillo W, Escobar GS, et al; Research Group for the Omega Women’s Health Project. Assessment of insomnia and related risk factors in postmenopausal women screened for the metabolic syndrome. Maturitas. 2013;74(2):154-9. | eng |
| dcterms.references | Hidalgo LA, Chedraui PA, Morocho N, Alvarado M, Chavez D, Huc A. The metabolic syndrome among postmenopausal women in Ecuador. Gynecological Endocrinol. 2006;22(8):447–54. doi: 10.1080/09513590600890272. | eng |
| dcterms.references | Mesch V, Boero L, Siseles N, Royer M, Prada M, Sayegh F. et al. Metabolic syndrome throughout the menopausal transition: influence of age and menopausal status. Climacteric. 2006;9(1):40–8. doi: 10.1080/13697130500487331. | eng |
| dcterms.references | Albuquerque J, Durans E, Barbosa J, De Flores F, Cardoso G, da Silva V, et al. Síndrome Metabólico y Menopausia: Estudio Transversal en Ambulatorio de Ginecología. Arq Bras Cardiol. 2010; 95(3): 339-345. | spa |
| dcterms.references | Eshtiaghia R, Esteghamatib A, Nakhjavani M. Menopause is an independent predictor of metabolic syndrome in Iranian women. Maturitas. 2010;65(3):262-6. | eng |
| dcterms.references | Monterrosa-Castro A, Blümel JE, Portela-Buelvas K, Mezones- Holguín E, Barón G, Bencosme A, et al; for the Collaborative Group for Research of the Climacteric in Latin America (REDLINC). Type II diabetes mellitus and menopause: a multinational study. Climacteric. 2013;16(6):663-72. | eng |
| dcterms.references | Esposito K, Chiodini P, Capuano A, Bellastella G, Maiorino MI, Rafaniello C, et al. Metabolic syndrome and postmenopausal breast cancer: systematic review and meta-analysis. Menopausia. 2013; 20(12):1301-9. | eng |
| dcterms.references | Rohan TE, Heo M, Choi L, Datta M, Freudenheim JL, Kamensky V, et al. Body fat and breast cancer risk in postmenopausal women: a longitudinal study. J CancerEpidemiol. 2013;2013:754815. | eng |
| dcterms.references | Hallajzadeh J, Khoramdad M, Izadi N, Karamzad N, Almasi A, Ayubi E et al. Metabolic syndrome and its components in premenopausal and postmenopausal women: a comprehensive systematic review and meta-analysis on observational studies. The Journal of the North American Menopause Society 2018; 25:1-10 | eng |
| dcterms.references | Lambrinoudaki I, Kazani A, Armeni E, Rizos D, Augoulea A, Kaparos G et al. The metabolic syndrome is associated with carotid atherosclerosis and arterial stiffness in asymptomatic, nondiabetic postmenopausal women, Gynecological Endocrinology 2018; 34:78-82, DOI: 10.1080/09513590.2017.1344208 | eng |
| dcterms.references | Vandana G, Sameeksha M, Supriya M, Sandeep K, Vani G. Association of Leptin: Adiponectin ratio and metabolic risk markers in postmenopausal women. Immunology Letters 2018; 196:63-67 | eng |
| dcterms.references | Steckling F, Boufleur J, da Cunha F, Lopes D, Bresciani G, Kretzmann N, et al. High-intensity interval training improves inflammatory and adipokine profiles in postmenopausal women with metabolic syndrome, Archives of Physiology and Biochemistry, 2018 DOI: 10.1080/13813455.2018.1437750 | eng |
| dcterms.references | Aschner P, Ruiz A, Balkau B, Massien C, Haffner SM; Latin America and the Caribbean International Day for Evaluation of Abdominal Adiposity (IDEA) National Coordinators and Investigators. Association of abdominal adiposity with diabetes and cardiovascular disease in Latin America. J Clin Hypertens (Greenwich). 2009;11(12):769-74. | eng |
| dcterms.references | Ortiz R, Torres M, Bermúdez V, Michel C, Illescas M, Rodas O, et al. La circunferencia abdominal elevada: un fenotipo asociado a múltiples factores de riesgo cardiovascular. Cumbe-Ecuador.Rev Síndrome Cardiometabolico y enfermedades crónicas degenerativas 2017;7(1):50-57 | eng |
| dcterms.references | Lobo R, Davis S, De Villiers T, Gompel A, Henderson V, Hodis H et al. Prevention of diseases after menopause, Climacteric 2014;17(5):540- 556, DOI: 10.3109/13697137.2014.933411 | eng |
| dcterms.references | Lobo R. Metabolic syndrome after menopause and the role of hormones. Maturitas 2008;20(60):10-18 | eng |
| dcterms.references | Polotsky H, Polotsky A. Metabolic implications of menopause. Semin Reprod Med 2010;28(5):426-434 | eng |
| dcterms.references | Chedraui P, Pérez-López FR, Escobar GS, Palla G, Montt-Guevara M, Cecchi E, Genazzani AR, Simoncini T, Research Group for the Omega Women’s Health Project. Circulating leptin, resistin, adiponectin, visfatin, adipsin and ghrelin levels and insulin resistance in postmenopausal women with and without the metabolic syndrome. Maturitas. 2014; 79(1):86-90. | eng |
| dcterms.references | Chedraui P, Escobar GS, Pérez-López FR, Palla G, Montt-Guevara M, Cecchi E, Genazzani AR, Simoncini T, Research Group for the Omega Women’s Health Project. Angiogenesis, inflammation and endothelial function in postmenopausal women screened for the metabolic syndrome. Maturitas. 2014;77(4):370-4. | eng |
| dcterms.references | Chacín M, Rojas J, Rodríguez D, Núñez M, Márquez M, Leal N, et al. Predisposición humana a la Obesidad, Síndrome Metabólico y Diabetes: El genotipo ahorrador y la incorporación de los diabetogenes al genoma humano desde la Antropología Biológica. Diabetes Internacional. 2011;3(2):36-49 | spa |
Archivos
Bloque original
1 - 1 de 1
Cargando...
- Nombre:
- La prevalencia del síndrome metabólico.pdf
- Tamaño:
- 209.26 KB
- Formato:
- Adobe Portable Document Format
- Descripción:
Bloque de licencias
1 - 1 de 1
No hay miniatura disponible
- Nombre:
- license.txt
- Tamaño:
- 368 B
- Formato:
- Item-specific license agreed upon to submission
- Descripción: